NASDAQ:SWAV ShockWave Medical Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding ShockWave Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $198.62 +7.45 (+3.90%) (As of 07/1/2022 12:00 AM ET) Add Compare Share Today's Range$190.01▼$199.3950-Day Range$115.91▼$198.6252-Week Range$113.36▼$249.73Volume350,118 shsAverage Volume543,614 shsMarket Capitalization$7.11 billionP/E Ratio257.95Dividend YieldN/APrice Target$207.86 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainability ShockWave Medical Stock Forecast (MarketRank)Analyst RatingModerate Buy2.83 Rating ScoreUpside/Downside4.7% Upside$207.86 Price TargetShort InterestHealthy3.88% of Shares Sold ShortDividend StrengthN/ASustainability-0.55Upright™ Environmental ScoreNews Sentiment0.45Based on 10 Articles This WeekInsider TradingSelling Shares$9.72 M Sold Last QuarterProj. Earnings Growth53.26%From $1.84 to $2.82 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.2.13 out of 5 starsMedical Sector327th out of 1,428 stocksSurgical & Medical Instruments Industry40th out of 137 stocks 1.4 Analyst's Opinion Consensus RatingShockWave Medical has received a consensus rating of Moderate Buy. The company's average rating score is 2.83, and is based on 5 buy ratings, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $207.86, ShockWave Medical has a forecasted upside of 4.7% from its current price of $198.62.Amount of Analyst CoverageShockWave Medical has only been the subject of 1 research reports in the past 90 days. Previous Next 3.0 Short Interest Percentage of Shares Shorted3.88% of the outstanding shares of ShockWave Medical have been sold short.Short Interest Ratio / Days to CoverShockWave Medical has a short interest ratio ("days to cover") of 2.2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in ShockWave Medical has recently increased by 12.10%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldShockWave Medical does not currently pay a dividend.Dividend GrowthShockWave Medical does not have a long track record of dividend growth. Previous Next 3.9 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreShockWave Medical has received a 72.86% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is driven by its "Diagnostic and treatment machines" and "Medical devices engineering" products. See details.Environmental SustainabilityThe Environmental Impact score for ShockWave Medical is -0.55. Previous Next 3.0 News and Social Media Coverage News SentimentShockWave Medical has a news sentiment score of 0.45. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.78 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 10 news articles for ShockWave Medical this week, compared to 2 articles on an average week.Search Interest24 people have searched for SWAV on MarketBeat in the last 30 days. This is an increase of 700% compared to the previous 30 days.MarketBeat Follows11 people have added ShockWave Medical to their MarketBeat watchlist in the last 30 days. This is an increase of 83% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, ShockWave Medical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $9,720,744.00 in company stock.Percentage Held by Insiders15.30% of the stock of ShockWave Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions89.06% of the stock of ShockWave Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for ShockWave Medical are expected to grow by 53.26% in the coming year, from $1.84 to $2.82 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of ShockWave Medical is 257.95, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 62.31.Price to Earnings Ratio vs. SectorThe P/E ratio of ShockWave Medical is 257.95, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 61.88.Price to Book Value per Share RatioShockWave Medical has a P/B Ratio of 29.00. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive SWAV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ShockWave Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address About ShockWave Medical (NASDAQ:SWAV)ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease (PAD); C2 catheters for treating coronary artery disease; and S4 catheters for treating below-the-knee PAD. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and sales managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.Read More SWAV Stock News HeadlinesJuly 2, 2022 | finance.yahoo.comDow Jones Futures: Stocks Bounce, But Don't Feed The Bear Market; BYD Vs. Tesla DeliveriesJuly 1, 2022 | finance.yahoo.comDow Jones Futures: Don't Feed The Bear Market; BYD Vs. Tesla DeliveriesJuly 1, 2022 | americanbankingnews.comShockWave Medical, Inc. (NASDAQ:SWAV) Insider Sells $792,000.00 in StockJune 28, 2022 | finance.yahoo.com3 Reasons to Add Masimo (MASI) Stock to Your Portfolio NowJune 28, 2022 | finance.yahoo.comIs ShockWave Medical (NASDAQ:SWAV) A Risky Investment?June 27, 2022 | finance.yahoo.comShockWave Medical Stock Scores Relative Strength Rating Jump To 89June 26, 2022 | americanbankingnews.comInsider Selling: ShockWave Medical, Inc. (NASDAQ:SWAV) VP Sells $11,119.70 in StockJune 25, 2022 | americanbankingnews.comInsider Selling: ShockWave Medical, Inc. (NASDAQ:SWAV) CFO Sells $217,890.00 in StockJune 25, 2022 | americanbankingnews.comAnalysts Set ShockWave Medical, Inc. (NASDAQ:SWAV) PT at $216.14June 23, 2022 | americanbankingnews.comShockWave Medical, Inc. (NASDAQ:SWAV) Director Frank T. Watkins Sells 3,000 SharesJune 23, 2022 | americanbankingnews.comShockWave Medical (NASDAQ:SWAV) vs. InfuSystem (NYSE:INFU) Financial ComparisonJune 17, 2022 | finance.yahoo.comPerkinElmer's (PKI) Arm Introduces Two CE-Marked AssaysJune 16, 2022 | americanbankingnews.comShockWave Medical (NASDAQ:SWAV) Trading Down 7%June 15, 2022 | finance.yahoo.comIs the Options Market Predicting a Spike in Shockwave Medical (SWAV) Stock?June 14, 2022 | finance.yahoo.comWhy ShockWave Medical Dipped TodayJune 14, 2022 | finance.yahoo.comShould You Consider Buying ShockWave Medical (SWAV) Shares?June 13, 2022 | finance.yahoo.comShockWave Medical Stock Shows Rising Price Performance With Jump To 91 RS RatingJune 13, 2022 | finance.yahoo.comShockwave Medical Stock Added To S&P 400 Index, Approaches New EntryJune 10, 2022 | americanbankingnews.comDouglas Evan Godshall Sells 7,400 Shares of ShockWave Medical, Inc. (NASDAQ:SWAV) StockJune 9, 2022 | finance.yahoo.comEarnings Estimates Rising for Shockwave Medical (SWAV): Will It Gain?June 8, 2022 | finance.yahoo.comShockwave Medical (SWAV) Up 35.4% Since Last Earnings Report: Can It Continue?June 8, 2022 | americanbankingnews.comShockWave Medical (NASDAQ:SWAV) Shares Gap Up to $162.32June 7, 2022 | nasdaq.comShockWave Medical (SWAV) Shares Cross Above 200 DMAJune 6, 2022 | finance.yahoo.comWhy Sotera Health Stock Crushed the Market TodayJune 6, 2022 | benzinga.comShockWave Medical's Return On Capital Employed OverviewSee More Headlines Industry, Sector and Symbol Stock ExchangeNASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:SWAV CUSIPN/A CIK1642545 Webwww.shockwavemedical.com Phone(510) 279-4262FaxN/AEmployees657Year FoundedN/ACompany Calendar Last Earnings5/09/2022Today7/02/2022Next Earnings (Estimated)8/08/2022Fiscal Year End12/31/2022Price Target and Rating Average Stock Price Forecast$207.86 High Stock Price Forecast$255.00 Low Stock Price Forecast$176.00 Forecasted Upside/Downside+4.7%Consensus RatingModerate Buy Rating Score (0-4)2.83333333333333 Research Coverage6 Analysts Profitability EPS (Most Recent Fiscal Year)$0.77 Trailing P/E Ratio257.95 Forward P/E Ratio107.95 P/E GrowthN/ANet Income$-9.14 million Net Margins9.70% Pretax Margin9.85% Return on Equity12.36% Return on Assets8.96% Debt Debt-to-Equity Ratio0.03 Current Ratio6.07 Quick Ratio5.03 Sales & Book Value Annual Sales$237.15 million Price / Sales29.98 Cash FlowN/A Price / Cash FlowN/A Book Value$6.85 per share Price / Book29.00Miscellaneous Outstanding Shares35,792,000Free Float30,316,000Market Cap$7.11 billion OptionableNot Optionable Beta1.49 ShockWave Medical Frequently Asked Questions Should I buy or sell ShockWave Medical stock right now? 6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ShockWave Medical in the last twelve months. There are currently 1 hold rating and 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" ShockWave Medical stock. View analyst ratings for ShockWave Medical or view top-rated stocks. What is ShockWave Medical's stock price forecast for 2022? 6 Wall Street research analysts have issued 12 month target prices for ShockWave Medical's shares. Their SWAV stock forecasts range from $176.00 to $255.00. On average, they predict ShockWave Medical's share price to reach $207.86 in the next year. This suggests a possible upside of 4.7% from the stock's current price. View analysts' price targets for ShockWave Medical or view top-rated stocks among Wall Street analysts. How has ShockWave Medical's stock price performed in 2022? ShockWave Medical's stock was trading at $178.33 on January 1st, 2022. Since then, SWAV stock has increased by 11.4% and is now trading at $198.62. View the best growth stocks for 2022 here. When is ShockWave Medical's next earnings date? ShockWave Medical is scheduled to release its next quarterly earnings announcement on Monday, August 8th 2022. View our earnings forecast for ShockWave Medical. How were ShockWave Medical's earnings last quarter? ShockWave Medical, Inc. (NASDAQ:SWAV) announced its quarterly earnings results on Monday, May, 9th. The company reported $0.39 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.19 by $0.20. The business had revenue of $93.70 million for the quarter, compared to analysts' expectations of $86.41 million. ShockWave Medical had a net margin of 9.70% and a trailing twelve-month return on equity of 12.36%. The company's revenue was up 193.7% on a year-over-year basis. During the same quarter in the previous year, the company earned ($0.68) EPS. View ShockWave Medical's earnings history. What guidance has ShockWave Medical issued on next quarter's earnings? ShockWave Medical issued an update on its FY 2022 earnings guidance on Monday, June, 6th. The company provided EPS guidance of for the period. The company issued revenue guidance of $435.00 million-$455.00 million, compared to the consensus revenue estimate of $417.90 million. Who are ShockWave Medical's key executives? ShockWave Medical's management team includes the following people: Mr. Douglas E. Godshall M.B.A., Pres, CEO & Director (Age 57, Pay $1.4M)Mr. Daniel Puckett MBA, CFO, Principal Financial Officer & Sec. (Age 58, Pay $658.71k)Mr. Isaac Zacharias, Chief Commercial Officer (Age 47, Pay $679.54k) (LinkedIn Profile)Mr. Daniel Hawkins, Founder and Sr. Advisor (Age 55)Mr. John M. Adams, Co-Founder and Technical Advisor (Age 75)Mr. Mike Maszy, VP of OperationsMs. Trinh Phung, Chief Accounting Officer, Principal Accounting Officer & VP of Fin. (Age 44) (LinkedIn Profile)Ms. Debbie Kaster, VP of Investor RelationsMr. Hajime Tada J.D., Gen. Counsel & Sec.Mr. Rob Williamson Jr., VP of Sales What is Doug Godshall's approval rating as ShockWave Medical's CEO? 8 employees have rated ShockWave Medical CEO Doug Godshall on Glassdoor.com. Doug Godshall has an approval rating of 89% among ShockWave Medical's employees. Who are some of ShockWave Medical's key competitors? Some companies that are related to ShockWave Medical include Fresenius SE & Co. KGaA (FSNUY), Insulet (PODD), Teleflex (TFX), Abiomed (ABMD), NovoCure (NVCR), Globus Medical (GMED), Inspire Medical Systems (INSP), Penumbra (PEN), Integra LifeSciences (IART), ICU Medical (ICUI), Tandem Diabetes Care (TNDM), Inari Medical (NARI), Haemonetics (HAE), iRhythm Technologies (IRTC) and Merit Medical Systems (MMSI). View all of SWAV's competitors. What other stocks do shareholders of ShockWave Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other ShockWave Medical investors own include NVIDIA (NVDA), Walt Disney (DIS), Square (SQ), Trade Desk (TTD), Salesforce (CRM), Roku (ROKU), PayPal (PYPL), DexCom (DXCM), Alibaba Group (BABA) and Okta (OKTA). When did ShockWave Medical IPO? (SWAV) raised $75 million in an initial public offering on Thursday, March 7th 2019. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. Morgan Stanley and BofA Merrill Lynch acted as the underwriters for the IPO and Wells Fargo Securities and Canaccord Genuity were co-managers. What is ShockWave Medical's stock symbol? ShockWave Medical trades on the NASDAQ under the ticker symbol "SWAV." How do I buy shares of ShockWave Medical? Shares of SWAV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is ShockWave Medical's stock price today? One share of SWAV stock can currently be purchased for approximately $198.62. How much money does ShockWave Medical make? ShockWave Medical (NASDAQ:SWAV) has a market capitalization of $7.11 billion and generates $237.15 million in revenue each year. The company earns $-9.14 million in net income (profit) each year or $0.77 on an earnings per share basis. How many employees does ShockWave Medical have? ShockWave Medical employs 657 workers across the globe. How can I contact ShockWave Medical? ShockWave Medical's mailing address is 5403 Betsy Ross Drive, Santa Clara CA, 95054. The official website for ShockWave Medical is www.shockwavemedical.com. The company can be reached via phone at (510) 279-4262 or via email at investors@shockwavemedical.com. This page (NASDAQ:SWAV) was last updated on 7/2/2022 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. MarketBeat Resources Premium Research Tools MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. Discover All Access Market Data and Calendars Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free. View Market Data Investing Education and Resources Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more. Financial Terms Details Here
